Lung Cancer Foundation of America
@lungcancerlcfa.bsky.social
Funding Early Career Researchers while raising Lung Cancer Awareness and providing Patient Education. Research + Awareness + Education = HOPE
“Did you smoke?” is often the first question asked of someone with lung cancer. It can feel like blame instead of support. Maida Mangiameli opens up about the harm this question causes and why understanding matters more than judgment. Explore her powerful story here: buff.ly/QBNWGOV
September 21, 2025 at 6:15 PM
“Did you smoke?” is often the first question asked of someone with lung cancer. It can feel like blame instead of support. Maida Mangiameli opens up about the harm this question causes and why understanding matters more than judgment. Explore her powerful story here: buff.ly/QBNWGOV
Lung cancer stigma often makes it harder for patients to share their experiences and seek support. Assumptions about smoking can overshadow the fact that anyone with lungs can get lung cancer. Open conversations and accurate information help shift the focus to awareness Learn more:
buff.ly/V0tP7z4
buff.ly/V0tP7z4
September 20, 2025 at 6:15 PM
Lung cancer stigma often makes it harder for patients to share their experiences and seek support. Assumptions about smoking can overshadow the fact that anyone with lungs can get lung cancer. Open conversations and accurate information help shift the focus to awareness Learn more:
buff.ly/V0tP7z4
buff.ly/V0tP7z4
Stigma keeps too many people with lung cancer from feeling understood and supported. Compassion and awareness can help change that conversation. Learn more about lung cancer stigma in the full episode of Hope With Answers: buff.ly/NgMoZxs
#LungCancer #Stigma #LivingWithLungCancer
#LungCancer #Stigma #LivingWithLungCancer
September 19, 2025 at 6:15 PM
Stigma keeps too many people with lung cancer from feeling understood and supported. Compassion and awareness can help change that conversation. Learn more about lung cancer stigma in the full episode of Hope With Answers: buff.ly/NgMoZxs
#LungCancer #Stigma #LivingWithLungCancer
#LungCancer #Stigma #LivingWithLungCancer
Dr. Jonathan Villena-Vargas explains how every stage of lung cancer now benefits from multimodality treatment by combining targeted therapies and immunotherapy. These approaches are improving outcomes for patients at all stages. Learn more about lung cancer treatment options here: buff.ly/JsMrTzx
September 14, 2025 at 6:15 PM
Dr. Jonathan Villena-Vargas explains how every stage of lung cancer now benefits from multimodality treatment by combining targeted therapies and immunotherapy. These approaches are improving outcomes for patients at all stages. Learn more about lung cancer treatment options here: buff.ly/JsMrTzx
Dr. Jacob Kaufman explains how each biomarker in lung cancer can lead to a treatment designed specifically for patients with that marker. Learn more about the impact of biomarker testing in lung cancer today: buff.ly/OpJwidX
#LungCancer #Biomarker #LungCancerResearch
#LungCancer #Biomarker #LungCancerResearch
September 13, 2025 at 6:15 PM
Dr. Jacob Kaufman explains how each biomarker in lung cancer can lead to a treatment designed specifically for patients with that marker. Learn more about the impact of biomarker testing in lung cancer today: buff.ly/OpJwidX
#LungCancer #Biomarker #LungCancerResearch
#LungCancer #Biomarker #LungCancerResearch
Biomarkers are unique signals in cancer cells that help doctors understand what is driving the disease. Knowing your biomarker can open the door to targeted therapies and personalized treatment plans, giving patients more options and better outcomes.
Learn more here: buff.ly/OpJwidX
Learn more here: buff.ly/OpJwidX
September 12, 2025 at 6:15 PM
Biomarkers are unique signals in cancer cells that help doctors understand what is driving the disease. Knowing your biomarker can open the door to targeted therapies and personalized treatment plans, giving patients more options and better outcomes.
Learn more here: buff.ly/OpJwidX
Learn more here: buff.ly/OpJwidX
Not every patient responds to immunotherapy in the same way. Dr. Kellie Smith explains which lung cancers are more likely to benefit and how doctors use testing to guide treatment decisions. Watch the full video here: buff.ly/OqAoIZh
#Immunotherapy #LungCancerResearch #LungCancer
#Immunotherapy #LungCancerResearch #LungCancer
September 7, 2025 at 6:15 PM
Not every patient responds to immunotherapy in the same way. Dr. Kellie Smith explains which lung cancers are more likely to benefit and how doctors use testing to guide treatment decisions. Watch the full video here: buff.ly/OqAoIZh
#Immunotherapy #LungCancerResearch #LungCancer
#Immunotherapy #LungCancerResearch #LungCancer
Scientific progress takes time and persistence. Dr. Kellie Smith explains how years of discovery at the intersection of the immune system and cancer have led to immunotherapy that is transforming lives. Watch the full video here: buff.ly/OqAoIZh
#Immunotherapy #CancerResearch #LungCancer
#Immunotherapy #CancerResearch #LungCancer
September 6, 2025 at 6:15 PM
Scientific progress takes time and persistence. Dr. Kellie Smith explains how years of discovery at the intersection of the immune system and cancer have led to immunotherapy that is transforming lives. Watch the full video here: buff.ly/OqAoIZh
#Immunotherapy #CancerResearch #LungCancer
#Immunotherapy #CancerResearch #LungCancer
Immunotherapy helps the immune system recognize and attack cancer cells. New research shows patients are seeing durable results that last long after treatment begins. Learn more about how this groundbreaking approach is advancing cancer treatment: buff.ly/Vgr158e
#Immunotherapy #LungCancerResearch
#Immunotherapy #LungCancerResearch
September 5, 2025 at 6:15 PM
Immunotherapy helps the immune system recognize and attack cancer cells. New research shows patients are seeing durable results that last long after treatment begins. Learn more about how this groundbreaking approach is advancing cancer treatment: buff.ly/Vgr158e
#Immunotherapy #LungCancerResearch
#Immunotherapy #LungCancerResearch
What exactly is small cell lung cancer (SCLC), and how does it differ from other lung cancers? Dr. Jacob Sands breaks it down in simple, clear terms. Watch the full Hope With Answers podcast episode to learn more about SCLC and the latest in lung cancer care: buff.ly/Yjv6S7T
August 31, 2025 at 6:15 PM
What exactly is small cell lung cancer (SCLC), and how does it differ from other lung cancers? Dr. Jacob Sands breaks it down in simple, clear terms. Watch the full Hope With Answers podcast episode to learn more about SCLC and the latest in lung cancer care: buff.ly/Yjv6S7T
Many people still picture chemotherapy as days of nausea and constant weakness. Dr. Jacob Sands explains how advances in anti-nausea medication have made treatment far more manageable than most expect. Watch the full Hope With Answers podcast episode for the complete conversation: buff.ly/Yjv6S7T
August 30, 2025 at 6:16 PM
Many people still picture chemotherapy as days of nausea and constant weakness. Dr. Jacob Sands explains how advances in anti-nausea medication have made treatment far more manageable than most expect. Watch the full Hope With Answers podcast episode for the complete conversation: buff.ly/Yjv6S7T
Thanks to new advances in treatment, patients are seeing better outcomes and a brighter future ahead. Hear from Dr. Jacob Sands and advocate Wendy Brooks as they share how innovation is reshaping care and bringing new hope to the SCLC community.
Watch here: buff.ly/Yjv6S7T
Watch here: buff.ly/Yjv6S7T
August 29, 2025 at 6:15 PM
Thanks to new advances in treatment, patients are seeing better outcomes and a brighter future ahead. Hear from Dr. Jacob Sands and advocate Wendy Brooks as they share how innovation is reshaping care and bringing new hope to the SCLC community.
Watch here: buff.ly/Yjv6S7T
Watch here: buff.ly/Yjv6S7T
Wendy Brooks talks about promising new therapies for small cell lung cancer, including bite therapy and targeted antibody drug conjugates. These treatments bring new hope by focusing directly on cancer cells. Learn more: buff.ly/2zzdc5p
#LivingWithLungCancer #SmallCellLungCancer
#LivingWithLungCancer #SmallCellLungCancer
August 24, 2025 at 6:15 PM
Wendy Brooks talks about promising new therapies for small cell lung cancer, including bite therapy and targeted antibody drug conjugates. These treatments bring new hope by focusing directly on cancer cells. Learn more: buff.ly/2zzdc5p
#LivingWithLungCancer #SmallCellLungCancer
#LivingWithLungCancer #SmallCellLungCancer
Every patient story carries the power to change how we see lung cancer. These stories show what’s possible, inspire others to keep going, and remind us why advocacy matters. Together, they’re shaping a brighter path forward. Learn more: buff.ly/M8xa68L
#LivingWithLungCancer #Advocacy
#LivingWithLungCancer #Advocacy
August 23, 2025 at 6:15 PM
Every patient story carries the power to change how we see lung cancer. These stories show what’s possible, inspire others to keep going, and remind us why advocacy matters. Together, they’re shaping a brighter path forward. Learn more: buff.ly/M8xa68L
#LivingWithLungCancer #Advocacy
#LivingWithLungCancer #Advocacy
Wendy Brooks shares why research is essential in the fight against lung cancer. While treatments can help, finding a cure remains the goal. Learn more about her story and how she continues to live and enjoy life: buff.ly/RcKN0Cn
#LivingWithLungCancer #LungCancer #Advocacy
#LivingWithLungCancer #LungCancer #Advocacy
August 22, 2025 at 6:15 PM
Wendy Brooks shares why research is essential in the fight against lung cancer. While treatments can help, finding a cure remains the goal. Learn more about her story and how she continues to live and enjoy life: buff.ly/RcKN0Cn
#LivingWithLungCancer #LungCancer #Advocacy
#LivingWithLungCancer #LungCancer #Advocacy
Annabelle Gurwitch shares how LCFA became her first stop after diagnosis, connecting her to the broader lung cancer community. Her story highlights the power of connection and support in the lung cancer journey. Watch the full episode here: buff.ly/EH3LUbE
August 17, 2025 at 6:16 PM
Annabelle Gurwitch shares how LCFA became her first stop after diagnosis, connecting her to the broader lung cancer community. Her story highlights the power of connection and support in the lung cancer journey. Watch the full episode here: buff.ly/EH3LUbE
Lisa Goldman shares why newly diagnosed lung cancer patients have more reason than ever to be hopeful. With new treatments and innovative combinations emerging, outcomes are improving. Keep an open mind as great results are happening every day. Learn more: buff.ly/8RZVaB2
August 16, 2025 at 6:15 PM
Lisa Goldman shares why newly diagnosed lung cancer patients have more reason than ever to be hopeful. With new treatments and innovative combinations emerging, outcomes are improving. Keep an open mind as great results are happening every day. Learn more: buff.ly/8RZVaB2
Awareness drives action. It helps people recognize symptoms sooner, boosts research funding, and influences policy changes that improve care. Every shared story moves us toward earlier detection and better outcomes. Read more in our Stories of Hope: buff.ly/ddq23PN
August 15, 2025 at 6:15 PM
Awareness drives action. It helps people recognize symptoms sooner, boosts research funding, and influences policy changes that improve care. Every shared story moves us toward earlier detection and better outcomes. Read more in our Stories of Hope: buff.ly/ddq23PN
Rick Wehe shares how pinpoint radiation helped eliminate tumors in both lungs—twice. Now he's back at the gym, doing yard work, and living life fully. Learn more about radiation therapy here: buff.ly/uOAbN3q #LivingWithLungCancer
August 10, 2025 at 6:15 PM
Rick Wehe shares how pinpoint radiation helped eliminate tumors in both lungs—twice. Now he's back at the gym, doing yard work, and living life fully. Learn more about radiation therapy here: buff.ly/uOAbN3q #LivingWithLungCancer
Jim & Gail Fackler never imagined their retirement years would include a stage 4 small cell lung cancer diagnosis. But through chemo, radiation, and immunotherapy, they've found strength in each other and joy in the little things. Learn more about their inspiring story here: buff.ly/9602zJY
August 9, 2025 at 6:16 PM
Jim & Gail Fackler never imagined their retirement years would include a stage 4 small cell lung cancer diagnosis. But through chemo, radiation, and immunotherapy, they've found strength in each other and joy in the little things. Learn more about their inspiring story here: buff.ly/9602zJY
Missed our World Lung Cancer Day Live? Catch the full replay on YouTube.
Hear from leading researchers and advocates as they discuss:
- New developments in lung cancer research
- The power of early detection
- What’s ahead in treatment and advocacy
🎥 Watch the full event here:
Hear from leading researchers and advocates as they discuss:
- New developments in lung cancer research
- The power of early detection
- What’s ahead in treatment and advocacy
🎥 Watch the full event here:
World Lung Cancer Day 2025
Share your videos with friends, family, and the world
buff.ly
August 8, 2025 at 5:45 PM
Missed our World Lung Cancer Day Live? Catch the full replay on YouTube.
Hear from leading researchers and advocates as they discuss:
- New developments in lung cancer research
- The power of early detection
- What’s ahead in treatment and advocacy
🎥 Watch the full event here:
Hear from leading researchers and advocates as they discuss:
- New developments in lung cancer research
- The power of early detection
- What’s ahead in treatment and advocacy
🎥 Watch the full event here:
In 2025, lung cancer is projected to kill 124,730 people in the U.S. That’s more deaths than any other cancer. This isn’t just a statistic—it’s a reflection of how far we still need to go in funding research, improving screening, and supporting patients. Learn more here: buff.ly/wdORvLN
August 3, 2025 at 6:15 PM
In 2025, lung cancer is projected to kill 124,730 people in the U.S. That’s more deaths than any other cancer. This isn’t just a statistic—it’s a reflection of how far we still need to go in funding research, improving screening, and supporting patients. Learn more here: buff.ly/wdORvLN
Lung cancer has a 5-year survival rate of only 28 percent—lower than breast, prostate, or colorectal cancer. Most cases are diagnosed too late, when treatment options are limited. Awareness and early detection can change that. Learn more here: buff.ly/wdORvLN
#LungCancer #LungCancerResearch #LCFA
#LungCancer #LungCancerResearch #LCFA
August 2, 2025 at 6:15 PM
Lung cancer has a 5-year survival rate of only 28 percent—lower than breast, prostate, or colorectal cancer. Most cases are diagnosed too late, when treatment options are limited. Awareness and early detection can change that. Learn more here: buff.ly/wdORvLN
#LungCancer #LungCancerResearch #LCFA
#LungCancer #LungCancerResearch #LCFA
Today is World Lung Cancer Day. Join us live from 9 AM to 1 PM PT on Facebook and YouTube for thoughtful conversations and new insights. Their experiences remind us why this work matters. Learn more: buff.ly/Foih3L9
#WLCD #WLCD25 #WorldLungCancerDay #LCFA #LungCancerResearch #LivingWithLungCancer
#WLCD #WLCD25 #WorldLungCancerDay #LCFA #LungCancerResearch #LivingWithLungCancer
August 1, 2025 at 1:15 PM
Today is World Lung Cancer Day. Join us live from 9 AM to 1 PM PT on Facebook and YouTube for thoughtful conversations and new insights. Their experiences remind us why this work matters. Learn more: buff.ly/Foih3L9
#WLCD #WLCD25 #WorldLungCancerDay #LCFA #LungCancerResearch #LivingWithLungCancer
#WLCD #WLCD25 #WorldLungCancerDay #LCFA #LungCancerResearch #LivingWithLungCancer
Patient advocate James Hiter takes us inside ASCO 2025, one of the world’s largest cancer research conferences. From poster sessions to conversations on the convention floor, see how researchers, clinicians, and advocates are shaping the future of cancer care.
buff.ly/FtSvR0E
buff.ly/FtSvR0E
July 27, 2025 at 6:15 PM
Patient advocate James Hiter takes us inside ASCO 2025, one of the world’s largest cancer research conferences. From poster sessions to conversations on the convention floor, see how researchers, clinicians, and advocates are shaping the future of cancer care.
buff.ly/FtSvR0E
buff.ly/FtSvR0E